^
Association details:
Biomarker:No biomarker
Cancer:Merkel Cell Carcinoma
Drug:Votrient (pazopanib) (Multi-tyrosine kinase inhibitor)
Direction:Sensitive
Evidence:
Evidence Level:
Sensitive: A2 - Guideline
Source:
Published date:
04/10/2023
Excerpt:
Merkel Cell Carcinoma...Useful in Certain Circumstances:...Tyrosine kinase inhibitors (pazopanib) (category 2B)